AlzeCure Pharma AB (publ) (STO:ALZCUR)
Sweden · Delayed Price · Currency is SEK 1.955
-0.035 (-1.76%)
At close: Feb 5, 2026
AlzeCure Pharma AB Market Cap
AlzeCure Pharma AB has a market cap or net worth of 224.66 million as of February 5, 2026. Its market cap has increased by 99.56% in one year.
Market Cap
224.66M
Enterprise Value
168.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.96
Market Cap Chart
Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 224.66M, a decrease of -45.92%. That is a compound annual growth rate of -8.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 224.66M | -2.25% |
| Dec 30, 2025 | 229.83M | 126.34% |
| Dec 30, 2024 | 101.54M | -47.41% |
| Dec 29, 2023 | 193.09M | -24.88% |
| Dec 30, 2022 | 257.04M | 14.39% |
| Dec 30, 2021 | 224.71M | -34.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipum AB | 294.85M |
| Bio-Works Technologies AB | 283.36M |
| Elicera Therapeutics AB | 249.96M |
| Xintela AB | 242.88M |
| Magle Chemoswed Holding AB | 235.40M |
| Xbrane Biopharma AB | 216.27M |
| Medivir AB | 202.80M |
| Initiator Pharma | 201.25M |